Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$479.06 - $630.38 $1.49 Million - $1.95 Million
-3,100 Reduced 12.06%
22,600 $11.2 Million
Q2 2024

Aug 14, 2024

SELL
$518.81 - $607.81 $3.74 Million - $4.38 Million
-7,200 Reduced 21.88%
25,700 $15 Million
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $12.7 Million - $14.5 Million
-26,900 Reduced 44.98%
32,900 $17.7 Million
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $16.4 Million - $17.6 Million
37,500 Added 168.16%
59,800 $27.7 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $885,025 - $1.07 Million
2,500 Added 12.63%
22,300 $9.53 Million
Q1 2023

May 15, 2023

SELL
$335.35 - $386.06 $18.2 Million - $21 Million
-54,400 Reduced 73.32%
19,800 $7.05 Million
Q4 2022

Feb 14, 2023

BUY
$346.68 - $397.58 $1.42 Million - $1.63 Million
4,100 Added 5.85%
74,200 $27.8 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $80.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.